Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$668,338
-$202,724 QoQ
Shares Held
5,290
-15.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,251
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. GILD ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $668,338 | 5,290 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $871,062 | 6,250 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,369,164 | 11,155 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,438,671 | 12,961 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,665,378 | 15,021 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,264,754 | 20,212 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,283,940 | 24,726 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,238,444 | 26,699 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,608,081 | 23,438 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,502,284 | 20,509 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,074,192 | 13,260 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,006,144 | 13,426 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $875,283 | 11,357 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,293,004 | 15,584 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,140,240 | 24,930 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,768,158 | 28,662 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,678,574 | 27,157 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,583,272 | 26,632 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,544,995 | 21,278 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,437,373 | 20,578 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,383,053 | 20,085 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,142,593 | 17,679 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $380,263 | 6,527 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $779,259 | 12,332 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $428,863 | 5,574 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,103,009 | 14,754 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||